Summary
Twenty-six patients with fulminant hepatic failure were treated with daily infusions of antithrombin III concentrate until recovery of consciousness or death. Seven patients were alive (group A), 7 survived 17 to 47 days after treatment (group B), and 12 died within 9 days (group C). Decreased plasma antithrombin III levels increased on the day after treatment, irrespective of the pretreatment levels in all patients. Continuous or temporary normalization was seen in all patients in groups A and B, but in only 5 in group C patients whose bleeding was extensive (p<0.05). An abrupt drop in peripheral platelet counts occurred when plasma antithrombin III levels were below normal. General bleeding accompanied this drop. These results suggest that maintained normal plasma antithrombin III levels are beneficial for prolonged survival time in fulminant hepatic failure, probably through controlling intravascular coagulation, and that antithrombin III infusion may be useful for such treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rake MO, Flute PT, Pannell G, et al: Intravascular coagulation in acute hepatic necrosis. Lancet 1970;i:533–537
Rake MO, Flute PT, Shiklin KB, et al: Early and intensive therapy of intravascular coagulation in acute liver failure. Lancet 1971;ii: 1215–1218
Hillenbrand P, Parbhoo SP, Jedrychowski A, et al: Significance of intravascular coagulation and fibrinolysis in acute hepatic failure. Gut 1974;15:83–88
Sherlock S: Acute (fulminant) hepatic failure. In: Diseases of the Liver and Biliary System. Blackwell Scientific Publications, Oxford. 1985;108–116
Rosenberg RD, Damus PS: The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973;248:6490–6505
Damus PS, Hicks M, Rosenberg RD: Anticoagulant action of heparin. Nature 1973;246:355–357
Verstraete M, Vermylen J, Collen D: Intravascular coagulation in liver disease. Annu Rev Med 1974;25:447–452
Laursen B, Mortensen JZ, Frost L, et al: Disseminated intravascular coagulation in hepatic failure treated with antithrombin III. Thromb Res 1981;22:701–704
Sakata Y, Yoshida N, Matsuda M, et al: Treatment of DIC with antithrombin III concentrates. Bibl Haematologica 1983;49:307–316
Vogel GE: Early treatment with AT III in acute liver failure. Behring Inst Mitt 1983;73:79–93
Takahashi Y: Acute hepatic failure-In special relation to treatment. Jap J Med 1983;22:140–145
Collen D, Schetz F, de Cock E, et al: Metabolism of antithrombin III (heparin cofactor) in man: effect of nevous thrombosis and of heparin administration. J Clin Invest 1977;7:27–35
Downing MR, Bloom JW, Mann KG: Comparison of the inhibition of thrombin by three protease inhibitors. Biochemistry 1978;17:2649–2653
Fujiwara K, Ogata I, Ohta Y, et al: Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III. Gut 1988; in press
Gazzard GB, Clark R, Borirakchanyavat V, et al: A controlled trials of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis. Gut 1974;15:89–93
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujiwara, K., Okita, K., Akamatsu, K. et al. Antithrombin III concentrate in the treatment of fulminant hepatic failure. Gastroenterol Jpn 23, 423–427 (1988). https://doi.org/10.1007/BF02779211
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02779211